| 1WP0 | B:; C: | HUMAN SCO1 |
| 2RII | A:; B: | CRYSTAL STRUCTURE OF HUMAN PEROXIREDOXIN I IN COMPLEX WITH SULFIREDOXIN |
| 2VL2 | A:; B:; C: | OXIDIZED AND REDUCED FORMS OF HUMAN PEROXIREDOXIN 5 |
| 2VL3 | A:; B:; C: | OXIDIZED AND REDUCED FORMS OF HUMAN PEROXIREDOXIN 5 |
| 2VL9 | A:; B:; C:; D: | OXIDIZED FORM OF HUMAN PEROXIREDOXIN 5 |
| 3HY2 | A:; B: | CRYSTAL STRUCTURE OF SULFIREDOXIN IN COMPLEX WITH PEROXIREDOXIN I AND ATP:MG2+ |
| 3MNG | A: | WILD TYPE HUMAN PRXV WITH DTT BOUND AS A COMPETITIVE INHIBITOR |
| 3TJB | A:; B:; C:; D:; E: | CRYSTAL STRUCTURE OF WILD-TYPE HUMAN PEROXIREDOXIN IV |
| 3TJF | A:; B:; C:; D:; E: | CRYSTAL STRUCTURE OF HUMAN PEROXIREDOXIN IV C51A MUTANT IN REDUCED FORM |
| 3TJG | A:; B:; C:; D:; E: | CRYSTAL STRUCTURE OF HUMAN PEROXIREDOXIN IV C51A MUTANT IN OXIDIZED FORM |
| 3TJJ | A:; B:; C:; D:; E: | CRYSTAL STRUCTURE OF HUMAN PEROXIREDOXIN IV C245A MUTANT IN SULFENYLATED FORM |
| 3TJK | A:; B:; C:; D:; E: | CRYSTAL STRUCTURE OF HUMAN PEROXIREDOXIN IV C245A MUTANT IN REDUCED FORM |
| 3TKP | A:; B:; C:; D:; E: | CRYSTAL STRUCTURE OF FULL-LENGTH HUMAN PEROXIREDOXIN 4 IN THE REDUCED FORM |
| 3TKQ | A:; B:; C:; D:; E: | CRYSTAL STRUCTURE OF FULL-LENGTH HUMAN PEROXIREDOXIN 4 WITH MIXED CONFORMATION |
| 3TKR | A:; J:; B:; C:; D:; E:; F:; G:; H:; I: | CRYSTAL STRUCTURE OF FULL-LENGTH HUMAN PEROXIREDOXIN 4 WITH T118E MUTATION |
| 3TKS | A:; B:; C:; D:; E: | CRYSTAL STRUCTURE OF FULL-LENGTH HUMAN PEROXIREDOXIN 4 IN THREE DIFFERENT REDOX STATES |
)
)